Distribution and elimination of intravenously injected urinary trypsin inhibitor.

Elimination of human urinary trypsin inhibitor (UTI) after intravenous injection of 125I-labelled UTI was followed by serial plasma and urine samples in three male volunteers. The plasma half-life of 125IUTI during 0-3 h after injection was 33 min and during the following 4 hours the half-life was 2 hours. Free, biologically active inhibitor was found in the urine during the first four hours after injection. Most of the radioactivity in the urine, however, corresponded to free 125I probably released during the degradation of UTI in the kidney. The distribution of UTI was studied after injection of 125IUTI in rats by measurement of radioactivity in excised organs. Fifteen min after the injection 44% of the radioactivity was found in the kidneys and 9% in the liver, implying that the kidneys are the primary site of UTI metabolism.

[1]  M. Maruyama,et al.  Distribution of acid stable trypsin inhibitor immunoreactivity in normal and malignant human tissues , 1989, Cancer.

[2]  M. Maruyama,et al.  Clearance and distribution of acid-stable trypsin inhibitor (ASTI). , 1989, Enzyme.

[3]  K. Ohlsson,et al.  Radioimmunological quantitation of the urinary trypsin inhibitor in normal blood and urine. , 1989, Biological chemistry Hoppe-Seyler.

[4]  B. Boniface,et al.  [Clinical value of the determination of urinary antitrypsin activity]. , 1988, Presse medicale.

[5]  M. Balduyck,et al.  Plasma proteins immunologically related to inter-α-trypsin inhibitor , 1988 .

[6]  E. Wachter,et al.  cDNA cloning of human inter-alpha-trypsin inhibitor discloses three different proteins. , 1987, Biological chemistry Hoppe-Seyler.

[7]  I. Byrjalsen,et al.  Human inter-alpha-trypsin inhibitor and immunologically related inhibitors investigated by quantitative immunoelectrophoresis. II. Pathological conditions. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[8]  Kerstin,et al.  Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. , 1986, The Journal of biological chemistry.

[9]  M. Balduyck,et al.  Human urinary proteinase inhibitor: inhibitory properties and interaction with bovine trypsin. , 1985, Biological chemistry Hoppe-Seyler.

[10]  K. Ohlsson,et al.  Interactions of the complex between human urinary trypsin inhibitor and human leukocyte elastase with alpha 1-proteinase inhibitor and alpha 2-macroglobulin. , 1984, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[11]  Maruyama Masugi,et al.  Marked increase of plasma acid stable/soluble trypsin inhibitor in hemodialysis patients , 1984 .

[12]  Jean‐Pierre Martin,et al.  Inter-α-trypsin inhibitor (ITI): Use of new antisera for qualitative studies and discrete quantitation of ITI and its derivatives , 1983 .

[13]  K. Ohlsson,et al.  Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin. , 1983, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[14]  K. Ohlsson,et al.  Human granulocyte elastase is inhibited by the urinary trypsin inhibitor. , 1982, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[15]  H. Sumi,et al.  Urinary trypsin inhibitor and urokinase activities in renal diseases. , 1982, Acta haematologica.

[16]  K. Ohlsson,et al.  Studies on the pancreatic secretory trypsin inhibitor in plasma and its complex with trypsin in vivo and in vitro. , 1978, Scandinavian journal of clinical and laboratory investigation.

[17]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.

[18]  T. Waldmann,et al.  The role of the kidney in the metabolism of plasma proteins. , 1974, Nephron.

[19]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[20]  H. Faarvang.  The excretion of trypsin inhibitor in urine during normal pregnancy. , 1959, Acta endocrinologica.

[21]  G. Dillard.  The trypsin inhibitor of the urine in health and disease. , 1950, The Journal of laboratory and clinical medicine.